Literature DB >> 6845378

Effects of aminoglycosides on glomerular permeability, tubular reabsorption, and intracellular catabolism of the cationic low-molecular-weight protein lysozyme.

C Cojocel, N Dociu, K Maita, S D Sleight, J B Hook.   

Abstract

Gentamicin and other aminoglycoside antibiotics in high doses may produce proteinuria and other signs of nephrotoxicity. Proteinuria may result from general renal damage or may reflect alterations in specific steps in the renal handling of proteins. To distinguish between these two possibilities, experiments were designed to quantify the effects of nephrotoxic doses of several aminoglycosides on the renal handling of proteins in the isolated perfused rat kidney with the cationic low-molecular-weight protein lysozyme as a representative protein. Each aminoglycoside was administered ip to male Wistar rats (30 mg/kg/day) for 7 days. Lysozyme and 125I-lysozyme were added to the perfusate to achieve a lysozyme perfusate concentration of about 100 mg/liter. Clearances of inulin and lysozyme, release of tyrosine and trichloroacetic acid-soluble radioactive metabolites into the perfusate, and the glomerular sieving coefficient of lysozyme were determined. Scanning and transmission electron microscopy indicated that gentamicin and tobramycin decreased the number and diameter of the endothelial fenestrae of the glomerular capillaries. Concurrently, gentamicin and tobramycin decreased the glomerular sieving coefficient of lysozyme from 0.8 to 0.6 and 0.5, respectively. Netilmicin did not affect the percentage reabsorption of lysozyme whereas gentamicin and tobramycin decreased lysozyme reabsorption from 71.7 to 35.4 and 34.4% of the filtered load, respectively. Lysozyme degradation, estimated by the release of tyrosine into the perfusate during a 150-min perfusion period, was decreased from a control value of 12 mumol/liter to 4.43 and 4.65 mumol/liter in kidneys from rats treated with gentamicin and tobramycin, respectively. This study demonstrates that polycationic aminoglycosides may affect several processes involved in renal handling of lysozyme including glomerular permeability, tubular reabsorption, and intracellular proteolytic degradation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6845378     DOI: 10.1016/0041-008x(83)90358-7

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  6 in total

1.  Effect of high saturated free fatty acids feeding on progression of renal failure in rat model of experimental nephrotoxicity.

Authors:  Zaid O Ibraheem; Munavvar A Sattar; Nor A Abdullah; Hassaan A Rathore; Edward J Johns
Journal:  Bosn J Basic Med Sci       Date:  2012-02       Impact factor: 3.363

2.  Dependence of renal protein reabsorption on glomerular filtration rate and infusion time.

Authors:  C Cojocel; M Franzen-Sieveking; W Berndt; K Baumann
Journal:  Pflugers Arch       Date:  1984-09       Impact factor: 3.657

3.  Garlic (Allium sativum) exhibits a cardioprotective effect in experimental chronic renal failure rat model by reducing oxidative stress and controlling cardiac Na+/K+-ATPase activity and Ca2+ levels.

Authors:  Asmaa M S Gomaa; Alaa T Abdelhafez; Hazem A Aamer
Journal:  Cell Stress Chaperones       Date:  2018-04-21       Impact factor: 3.667

4.  Renal processing of low molecular weight proteins.

Authors:  C Cojocel; K Maita; K Baumann; J B Hook
Journal:  Pflugers Arch       Date:  1984-08       Impact factor: 3.657

5.  Impact of gentamicin coadministration along with high fructose feeding on progression of renal failure and metabolic syndrome in Sprague-Dawley rats.

Authors:  Zaid O Ibraheem; Rusliza Basir; Ahmad Kh Aljobory; Omar E Ibrahim; Ajwad Alsumaidaee; Mun Fee Yam
Journal:  Biomed Res Int       Date:  2014-06-23       Impact factor: 3.411

Review 6.  Renal ultrastructural and biochemical injuries induced by aminoglycosides.

Authors:  C Cojocel; N Docius; K Maita; J H Smith; J B Hook
Journal:  Environ Health Perspect       Date:  1984-08       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.